Demcizumab

demcizumab · OncoMed Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Demcizumab, covering 2018-08-08 to 2018-08-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer [Phase 2]

See pricing